CAS 35180-01-9: Unlocking New Possibilities in Pharmaceutical Chemistry

Category: Knowledge

Time: 2025-08-29

Summary: CAS 35180-01-9: Unlocking New Possibilities in Pharmaceutical Chemistry Table of Contents 1. Introduction to CAS 35180-01-9 and Its Importance in Pharmaceutical Chemistry 2. Chemical Properties of CAS 35180-01-9 3. Synthesis Methods for CAS 35180-01-9 4. Applications of CAS 35180-01-9 in Drug Development 5. The Therapeutic Potential of CAS 35180-01-9 6. Challenges in Utili

CAS 35180-01-9: Unlocking New Possibilities in Pharmaceutical Chemistry


Table of Contents



1. Introduction to CAS 35180-01-9 and Its Importance in Pharmaceutical Chemistry


In the ever-evolving landscape of pharmaceutical chemistry, CAS 35180-01-9 has emerged as a pivotal intermediate compound. Pharmaceutical researchers and chemists are increasingly turning their attention to this compound due to its unique properties and versatile applications. As the industry explores new frontiers in drug formulation and efficacy, understanding CAS 35180-01-9 becomes essential.
This article delves into the significance of CAS 35180-01-9, exploring its chemical properties, synthesis methods, applications, therapeutic potential, challenges, and future outlook. By the end, readers will appreciate the contributions of CAS 35180-01-9 to modern medicinal chemistry.

2. Chemical Properties of CAS 35180-01-9


CAS 35180-01-9 is characterized by a unique chemical structure that influences its reactivity and compatibility with various biological systems. With a molecular formula of C10H12N2O2, this compound consists of a benzene ring fused with an amide and a carbonyl group, giving it both hydrophilic and lipophilic properties.
These chemical properties play a crucial role in the compound's solubility, stability, and interaction with target biomolecules. Understanding these properties is vital for pharmaceutical applications, allowing researchers to predict how CAS 35180-01-9 will behave in biological environments.

Physical Properties


The physical properties of CAS 35180-01-9, including melting point, boiling point, and solubility, are key indicators of its potential use in drug formulation. Typically, this compound exhibits high solubility in organic solvents and moderate solubility in water. Such solubility characteristics can enhance the bioavailability of drugs developed using this compound, thereby improving therapeutic outcomes.

3. Synthesis Methods for CAS 35180-01-9


The synthesis of CAS 35180-01-9 involves several methodologies, each with its advantages and challenges. The choice of synthesis route often depends on the intended application and desired purity of the final product.

Conventional Synthesis Techniques


Traditional synthesis methods, such as refluxing and condensation reactions, have been employed to create CAS 35180-01-9. These methods typically involve carefully controlled reaction conditions to yield high purity and desired quantities.

Green Chemistry Approaches


In light of environmental concerns, researchers are increasingly exploring green chemistry methods for synthesizing CAS 35180-01-9. These approaches not only minimize waste but also reduce the use of hazardous reagents. Techniques such as enzymatic synthesis and microwave-assisted reactions have shown promise in enhancing efficiency and sustainability.

4. Applications of CAS 35180-01-9 in Drug Development


CAS 35180-01-9 serves as an important intermediate in the synthesis of various pharmaceuticals. Its structural features enable it to act as a building block for a diverse array of therapeutic compounds.

Link to Antiviral Agents


One notable application of CAS 35180-01-9 is its role in developing antiviral agents. Current research indicates that derivatives of CAS 35180-01-9 exhibit significant activity against various viral strains, opening avenues for innovative treatments.

Role in Anticancer Drug Formulation


Pharmaceutical chemists are also investigating the potential of CAS 35180-01-9 in anticancer drug formulation. Preliminary studies suggest that this compound may enhance the efficacy of certain chemotherapeutic agents, thereby improving patient outcomes.

5. The Therapeutic Potential of CAS 35180-01-9


The therapeutic implications of utilizing CAS 35180-01-9 in drug development extend beyond simple applications. This compound plays a critical role in enhancing the pharmacokinetics and pharmacodynamics of drugs.

Improving Bioavailability


One of the major challenges in drug formulation is ensuring adequate bioavailability. CAS 35180-01-9, with its favorable solubility profile, can significantly improve the absorption and distribution of active pharmaceutical ingredients (APIs), ensuring they reach their intended targets effectively.

Synergistic Effects with Other Compounds


Moreover, CAS 35180-01-9 can demonstrate synergistic effects when combined with other compounds, leading to enhanced therapeutic efficacy. Researchers are actively exploring these combinations to develop more potent and targeted therapies.

6. Challenges in Utilizing CAS 35180-01-9


While the potential of CAS 35180-01-9 in pharmaceutical chemistry is promising, several challenges must be addressed to fully exploit its applications.

Regulatory Hurdles


Navigating the regulatory landscape can be daunting for researchers and manufacturers alike. Ensuring compliance with stringent guidelines and obtaining the necessary approvals for new drug formulations involving CAS 35180-01-9 can be time-consuming and resource-intensive.

Scalability and Cost-Effectiveness


Additionally, the scalability of synthesis methods and cost-effectiveness of using CAS 35180-01-9 in drug development remain critical concerns. Researchers must balance the benefits of utilizing this intermediate with the economic feasibility of production.

7. Future Outlook on CAS 35180-01-9 in Pharmaceutical Research


Looking ahead, the future of CAS 35180-01-9 in pharmaceutical research appears optimistic. As advancements in synthetic methodologies continue to emerge, the application of this compound is likely to expand.

Emphasis on Personalized Medicine


With the growing emphasis on personalized medicine, CAS 35180-01-9 may play a crucial role in developing tailored therapies. By understanding individual patient characteristics, researchers can utilize this compound to create more effective and specific treatments.

Integration of Technology in Research


Furthermore, the integration of technological advancements, such as artificial intelligence and machine learning, into pharmaceutical research will undoubtedly enhance the discovery process. These technologies can facilitate the identification of new applications for CAS 35180-01-9, further expanding its impact on drug development.

8. Frequently Asked Questions About CAS 35180-01-9


What is the significance of CAS 35180-01-9 in pharmaceuticals?


CAS 35180-01-9 is a key intermediate in the synthesis of various pharmaceutical compounds, enhancing their bioavailability and therapeutic efficacy.

How is CAS 35180-01-9 synthesized?


CAS 35180-01-9 can be synthesized using conventional methods or green chemistry approaches, focusing on efficiency and environmental sustainability.

What are the current applications of CAS 35180-01-9?


CAS 35180-01-9 is being explored for use in antiviral and anticancer drug formulations, among other therapeutic areas.

What challenges exist when working with CAS 35180-01-9?


Challenges include regulatory hurdles, scalability issues, and the need for cost-effective production methods.

What does the future hold for CAS 35180-01-9?


The future of CAS 35180-01-9 in pharmaceutical research looks promising, especially with advancements in personalized medicine and technology integration.

9. Conclusion


In summary, CAS 35180-01-9 stands as a cornerstone in the field of pharmaceutical chemistry, unlocking new possibilities for drug development and therapeutic applications. As researchers continue to explore its chemical properties and potential uses, this intermediate compound is poised to make significant contributions to the advancement of modern medicine. The future of CAS 35180-01-9 is bright, with ongoing research paving the way for innovative treatments that could enhance patient outcomes across various medical disciplines.

Keywords: CAS 35180-01-9: Unlocking New Possibilities in Pharmaceutical Chemistry

Blogs

Knowledge